The results suggested that SND1 was significantly overexpressed in various cancer tissues than that in the corresponding normal tissues, including colon adenocarcinoma (COAD), lymphoid neoplasm diffuse large B-cell lymphoma (DLBC), liver hepatocellular carcinoma (LIHC), prostate adenocarcinoma (PRAD), skin cutaneous melanoma (SKCM), testicular germ cell tumors (TGCT), thymoma (THYM), glioblastoma (GBM), and lower grade glioma (LGG). This evidence concerns the gene SND1 and diffuse large B-cell lymphoma.